HAPPY AUDIT, L. Bjerrum, March 9 - Grace
HAPPY AUDIT, L. Bjerrum, March 9 - Grace
HAPPY AUDIT, L. Bjerrum, March 9 - Grace
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Health<br />
Alliance for Prudent<br />
Prescribing,<br />
Yield<br />
se of anti-microbial<br />
Drugs<br />
In n the Treatment<br />
of Respiratory Tract Infections<br />
And<br />
Use<br />
Proposal for EU DG Research, <strong>March</strong> 2006<br />
Coordinator: Research Unit of General Practice, Odense, Denmark
Research Unit for General Practice<br />
University of Southern Denmark
<strong>HAPPY</strong> <strong>AUDIT</strong><br />
Objective<br />
to reduce the occurrence of bacterial<br />
resistance<br />
by reducing prescribing of unnecessary<br />
antibiotics for respiratory tract infections<br />
by improving the use of appropriate<br />
antibiotics in suspected bacterial<br />
infections<br />
by Improving the quality of diagnostic<br />
procedures for RTIs in general practice
El PAIS, 2001
Correlation between penicillin use and prevalence of resistancy<br />
Gossens et al: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.<br />
The Lancet 2005
Participation of 450 GPs<br />
12<br />
from 12 regions<br />
Country<br />
Local<br />
No of<br />
Region<br />
partner<br />
GPs<br />
Denmark APOR<br />
1 Funen 100<br />
Sweden BIRD<br />
2 Blekinge 50<br />
Lithuania FDC<br />
3 Klaipeda 30<br />
Russia AFMK<br />
4 Kaliningrad 30<br />
France CPMF<br />
5 Paris 30<br />
Spain SEMFYC<br />
6 Madrid 30<br />
7 Catalonia 30<br />
8 Valencia 30<br />
9 Andalusia 30<br />
10 Galicia 30<br />
11 Gran Canaria 30<br />
Argentina 12 Missiones 30<br />
Total 450<br />
10<br />
9<br />
6<br />
5<br />
8<br />
7<br />
1<br />
2<br />
4<br />
3<br />
11
Facts:<br />
Antibiotic treatment in general practice<br />
GPs are responsible for >90% of all prescriptions<br />
of antibiotics in most countries<br />
The majority of prescriptions are for patients with<br />
respiratory tract infections<br />
Most respiratory tract infections are caused<br />
by virus<br />
Most respiratory infections are not dangerous<br />
Very few respiratory infections are serious or<br />
life threatening<br />
Only few respiratory infections need acute<br />
treatment<br />
Most prescriptions are issued for fear of<br />
serious infections – “just for sake”<br />
Overuse of antibiotics may lead to increased<br />
number of resistant bacteria
Distribution of focus for<br />
infections in General Practice<br />
Eyes<br />
11%<br />
Gyn<br />
5%<br />
GI<br />
1%<br />
Skin<br />
12%<br />
Urine<br />
12%<br />
Respiratory Tract<br />
60%<br />
Bronchii<br />
11%<br />
Lungs<br />
7%<br />
Ears<br />
8%<br />
Sinuses<br />
12%<br />
Tonsils<br />
17%<br />
Other<br />
4%
Some characteristics of Primary health<br />
care in participating countries<br />
Time allocated for a consultation<br />
Nordic countries: 10-15 15 minutes<br />
Spain 5-65<br />
6 minutes<br />
Diagnostic test in patients with<br />
respiratory tract infections<br />
<br />
<br />
Nordic countries: StrepA, CRP<br />
Spain, France: No tests<br />
Antibiotic treatment<br />
<br />
<br />
Nordic countries<br />
Narrow spectrum penicillin<br />
represents >50% of all<br />
prescriptions<br />
Spain, France<br />
Narrow spectrum penicillin are<br />
hardly not used
Different practice organization in<br />
Practice organization<br />
Denmark<br />
participating countries<br />
GPs are independent<br />
professionals working on a<br />
contractual base with the<br />
government (county)<br />
GPs are owners of practice<br />
Group practices of 2-42<br />
4 GPs<br />
Solo practices<br />
Spain<br />
GPs are employed by the NHS<br />
Health centres with 20-30 GPs<br />
per centre
Different pattern of contact to<br />
Denmark, Sweden:<br />
<br />
General Practice<br />
The GP represents the point of<br />
first encounter for >95% of<br />
people suffering health problems<br />
Spain, France<br />
<br />
Patients can contact other<br />
specialist directly<br />
Denmark, Sweden<br />
<br />
GPs are responsible for >90% of<br />
all prescriptions issued<br />
Spain, France<br />
<br />
GPs are responsible for the<br />
majority of prescriptions, but<br />
patients may also get antibiotics<br />
from:<br />
“Under the counter”<br />
prescriptions<br />
Other specialists
Audit Project<br />
Odense (APO)<br />
Organised as a quality development program within<br />
the Research Unit of General Practice, University of<br />
Southern Denmark<br />
Financed by research grants combined with fees for<br />
services<br />
Has activities in all Danish counties and all Nordic<br />
countries, incl. Greenland and The Faroe Islands<br />
Aims to combine well-known postgraduate training<br />
methods with a view to effectively implementing<br />
guidelines and new knowledge in general practice<br />
It is based on simple prospective self-registration<br />
It is voluntary
The APO method: A simple and practical method for quality<br />
development in primary care
Number of consultations today:<br />
Registration date:<br />
1<br />
2<br />
3<br />
4<br />
5<br />
6<br />
7<br />
8<br />
9<br />
10<br />
11<br />
12<br />
13<br />
14<br />
15<br />
sex<br />
day month year<br />
%<br />
Infection focus<br />
only 1 x<br />
1 - 3 x<br />
3 4 5 6 7 8 9 10 11 12 13 16<br />
only 1 x<br />
only 1 x<br />
min. 1 max. 7 x<br />
30<br />
only 1 x<br />
Remarks<br />
Copyright: Audit Projekt Odense, Winsløwparken 19 - 5000 Odense C, DK<br />
Number of consultations today:<br />
Registration date:<br />
1<br />
2<br />
3<br />
4<br />
5<br />
6<br />
7<br />
8<br />
9<br />
10<br />
11<br />
12<br />
13<br />
14<br />
15<br />
day<br />
sex<br />
month year<br />
%<br />
Type of<br />
contact Infection focus<br />
form<br />
only 1 x only 1 x only 1 x<br />
1 - 3 x<br />
3 4 5 6 7 8 9 10 11 12 13 16<br />
only 1 x<br />
only 1 x<br />
min. 1 max. 7 x<br />
30<br />
Certificate<br />
(sick-leave)<br />
only 1 x<br />
Remarks<br />
Copyright: Audit Projekt Odense, Winsløwparken 19 - 5000 Odense C, DK<br />
% af regi streringer<br />
100%<br />
75%<br />
50%<br />
25%<br />
0%<br />
Nor mal t<br />
O TOS KO PIFUN D<br />
Pat ologi sk<br />
norm al undertry k flad kurve andet ubrugel ig<br />
The Audit circle:<br />
GP:<br />
0 1<br />
<strong>AUDIT</strong>: Respiratory Infections in General Practice - 2001<br />
Contact<br />
Diagnosis and<br />
treatment<br />
Infection Antibiotic<br />
origin treatment<br />
Choice of antibiotics<br />
Date of Birth<br />
Total<br />
␇ 1 2 3 4 5 11 14 15 17 18 19 20 21 22 23 24 25 26 27 28 29 31 32 33<br />
First pilot<br />
First registration<br />
TYMPANOMETRIFUND RELATERET TIL OTOSKOPI FUND<br />
Project group<br />
First follow-up meeting<br />
Idea<br />
Analysis of<br />
quality problems<br />
Implementation strategy<br />
Final courses<br />
and evaluation<br />
GP:<br />
0 1<br />
Date of Birth<br />
Total<br />
<strong>AUDIT</strong>: Respiratory Infections in General Practice - 2001<br />
Con-<br />
only 1 x only 1 x<br />
Type of<br />
contact tact<br />
form<br />
Diagnosis and Infection<br />
treatment origin<br />
Antibiotic<br />
treatment<br />
Choice of antibiotics<br />
␇ 1 2 3 4 5 11 14 15 17 18 19 20 21 22 23 24 25 26 27 28 29 31 32 33<br />
Certificate<br />
(sick-leave)<br />
Courses<br />
Reminders<br />
Workshops<br />
Second registration
Guidelines - respiratory<br />
tract infections<br />
1995<br />
1997<br />
1999<br />
2002<br />
2004<br />
2006<br />
1992-93<br />
FIRST<br />
REGISTRATION<br />
Editorial<br />
board<br />
FINAL CONFERENCE<br />
CONSENSUS CONFERENCE<br />
SECOND<br />
REGISTRATION<br />
NEWSLETTER<br />
STRATEGY<br />
CONFERENCE<br />
NEWSLETTERv<br />
NEWSLETTERS
Change in treatment of pneumonia in<br />
Denmark 1992-1995<br />
70<br />
PERCENT<br />
60<br />
50<br />
40<br />
30<br />
20<br />
10<br />
0<br />
PENI-<br />
CILLIN<br />
AMPI-<br />
CILLIN<br />
ERYTHRO-<br />
MYCIN<br />
TETRA-<br />
CYCLINE<br />
OTHER<br />
ANTIB.<br />
OTHER<br />
MED.<br />
NO<br />
MED.<br />
24 G.P.'s<br />
1992 n=62 1993 n=127 1995 n=107
Antibiotic Audit 2001: variation between GPs<br />
Antibiotic prescription for tonsillitis in different practices in i<br />
Denmark before intervention<br />
Practices (%)<br />
30<br />
25<br />
20<br />
15<br />
10<br />
5<br />
0<br />
Consultations (%)<br />
90-100%<br />
80-89%<br />
70-79%<br />
60-69%<br />
50-59%<br />
40-49%<br />
30-39%<br />
20-29%<br />
10-19%<br />
0-9%
Antibiotic Audit 2002: variation between GPs<br />
Antibiotic prescription for tonsillitis in different practices in i<br />
Denmark after intervention<br />
Practices (%)<br />
40<br />
35<br />
30<br />
25<br />
20<br />
15<br />
10<br />
5<br />
0<br />
Consultations (%)<br />
90-100%<br />
80-89%<br />
70-79%<br />
60-69%<br />
50-59%<br />
40-49%<br />
30-39%<br />
20-29%<br />
10-19%<br />
0-9%
European Audit 2001<br />
Treatment of tonsillitis in different countries<br />
80<br />
70<br />
60<br />
50<br />
40<br />
30<br />
20<br />
10<br />
0<br />
Denmark Norway Sweden Spain<br />
Cephalosporine<br />
Macrolide<br />
Amoxacillin<br />
V-penicillin
European Audit 2001<br />
Use of tests in patients with tonsillitis in different countries<br />
100<br />
90<br />
80<br />
70<br />
60<br />
50<br />
40<br />
30<br />
20<br />
10<br />
0<br />
Denmark Norway Sweden Spain<br />
No test<br />
Other<br />
CRP<br />
StrepA
Percentage of consultations with antibiotic prescribing in relation to<br />
focus for infection<br />
%<br />
80<br />
70<br />
60<br />
50<br />
40<br />
30<br />
Before intervention<br />
After Intervention<br />
20<br />
10<br />
0<br />
Ears<br />
Tonsils<br />
Pharynx<br />
Sinuses<br />
Bronchii/lungs<br />
Multiple foci<br />
Unknown focus<br />
All resp infections<br />
Focus for respiratory infection
Main results<br />
Effects of change<br />
The intervention led to a significant reduction in antibiotic<br />
prescribing.<br />
Before the intervention 36% (29%-44%) of consultations were<br />
followed by antibiotic prescribing<br />
After the intervention 24% (20%-29%) 29%) of consultations were<br />
followed by antibiotic prescribing<br />
The reduction was most pronounced in patients with sinusitis<br />
and lower RTIs.<br />
Lessons learnt<br />
Improvement of diagnostic procedures may lead to a<br />
reduction of antibiotic prescribing in primary health care<br />
in Spain.
How do we influence doctors to change<br />
their prescribing habbits ?<br />
Written material<br />
Training courses<br />
Prescription feedback<br />
Reminders<br />
Academic detailing<br />
Audit interventions<br />
Guidelines combined<br />
with other initiatives<br />
Etc…
How can doctors change habbits<br />
concerning antibiotic use?<br />
Important conditions for change<br />
of habbits<br />
Recognize that there is a<br />
problem, and something has<br />
to be changed<br />
Motivation and willingness to<br />
change habbits<br />
Feeling of a personal<br />
responsiblility for<br />
participating in the<br />
intervention
Experience from audit<br />
When performing guidelines<br />
for general practice they<br />
should be adapted to local<br />
conditions<br />
Initiatives should be taken to<br />
implement them in the most<br />
effective way, adapted to<br />
local conditions<br />
When introducing guidelines<br />
they should be followed up<br />
by other initiatives
What do patients with respiratory<br />
infections want from the GP ?<br />
Some patients with RTI expect the doctor to perform a test<br />
to confirm that they don’t t need antibiotics<br />
Frequent in Nordic countries<br />
Infrequent in Southern Europe<br />
Some patients with RTI expect the doctor to issue an<br />
antibiotic prescription for their symptoms<br />
Doctors are highly influenced by patients demand<br />
Prescribing may be a way of showing the patient<br />
that the doctor understands and accepts the<br />
patient’s s problem and is willing to help.
Why are antibiotics prescribed for non-<br />
bacterial infections ?<br />
Doctors may be too busy to perform a<br />
thorough examination or a laboratory<br />
investigation<br />
In a busy practice, a prescription can be used<br />
to terminate the consultation<br />
If you are in doubt you may prescribe ”just to<br />
be safe”
The consortium<br />
Participant organisation name<br />
Short name<br />
Type<br />
Research<br />
Country<br />
Internat.<br />
Health<br />
authority<br />
Assoc.<br />
of GPs<br />
SME<br />
Research Unit for General Practice in Odense RUPO DK GOV X<br />
GP Consultants GPC DK PRC X<br />
Ministry of the Interior and Health MIH DK GOV X<br />
Blekinge Institute for Research and Development BIRD SE PNP X<br />
National Board of Health and Welfare NBHW SE GOV X<br />
FD Centre FDC LT PNP X<br />
State Patient Fund SPF LT GOV X<br />
Association of Family Doctors, Kaliningrad AFMK RU PNP X<br />
College of Family Physicians in Paris CPMF FR PNP X<br />
Spanish Society of Family Medicine SEMFYC ES PNP X<br />
University of Las Palmas de Gran Canaria ULPGC ES GOV X<br />
Consejería de Sanidad del Gobierno de Canarias CSGC ES GOV X<br />
Misiones Association of General Family Medicine and<br />
Health Team<br />
AMMeGeFES AR PNP X<br />
World Health Organisation, Collaborating Centre for<br />
Drug Statistics Methodology<br />
WHO-CC NO INO X X<br />
World Organisation of Family Doctors WONCA SI INO X X X<br />
European Drug Utilisation Research Group EuroDURG BE INO X X<br />
17 participants from 8 EU countries and 2 INCO countries
Project structure<br />
Planning of audits and intervention<br />
WP2<br />
Planning of<br />
Audit<br />
cycles<br />
WP3<br />
Development<br />
of<br />
Indicators<br />
WP4<br />
Intervention<br />
material<br />
for Patients<br />
WP5<br />
Intervention<br />
for<br />
Professionals<br />
Audit<br />
implementation<br />
plan<br />
Audit<br />
guideline<br />
Intervention<br />
material for<br />
patients<br />
Intervention<br />
material for<br />
professionals<br />
Initial registration<br />
Intervention<br />
WP6 APO cycles in the Nordic Region (2 APO cycles)<br />
WP7 APO cycles in the Baltic Region (2 APO cycles)<br />
Final registration<br />
GP<br />
registration<br />
data<br />
WP10 Analysis<br />
of the audit<br />
results<br />
WP8 APO cycles in France (1 APO cycle)<br />
WP9 APO cycles in Hispano-America (7 APO cycles)<br />
Understanding the<br />
effect of intervention<br />
Analysis and dissemination<br />
WP11<br />
Evaluation and<br />
working<br />
conference<br />
Conclusions and<br />
recommendations<br />
GP<br />
registration<br />
data<br />
WP12<br />
Preparing<br />
material for<br />
media<br />
campaigns
Project time schedule<br />
2007 2008 2009 2010<br />
X<br />
X<br />
Analysis and conference<br />
Second registration of Patients<br />
Intervention: GPs and patients<br />
First registration of Patients<br />
First invitation of GPs<br />
Total project period: 3 years (April 2007 – <strong>March</strong> 2010)
Dissemination<br />
Follow-up meetings for GPs in each region<br />
<strong>HAPPY</strong> <strong>AUDIT</strong> Conference (month 36)<br />
Scientific publications and conference presentations<br />
Media campaigns targeting professionals and the<br />
public (to be financed by EU in separate projects)<br />
<strong>HAPPY</strong> <strong>AUDIT</strong><br />
<strong>HAPPY</strong> <strong>AUDIT</strong><br />
<strong>HAPPY</strong><br />
<strong>AUDIT</strong>
Time schedule<br />
First partner meeting: October 2005<br />
Submission to EU: <strong>March</strong> 2006<br />
Evaluation by EU: July 2006<br />
Contract negotiation: November 2006<br />
Project start: April 2007<br />
First registration: January 2008 *<br />
Second registration: January 2009 *<br />
End of project: <strong>March</strong> 2010<br />
* Plus 6 months for Argentina
Project time schedule<br />
Work package<br />
WP1 Project Management<br />
WP2 Planning of audit cycles<br />
WP3 Development of indicators<br />
WP4 Intervention materials for Patients<br />
WP5 Intervention materials for Professionals<br />
WP6 APO cycles in the Nordic Region (2 APO cycles)<br />
WP7 APO cycles in the Baltic Region (2 APO cycles)<br />
WP8 APO cycles in France (1 APO cycle)<br />
WP9 APO cycles in Hispano-America (6 APO cycles)<br />
WP10 Analysis of the audit results<br />
WP11 Evaluation and working conference<br />
WP12 Preparing material for media campaigns<br />
M1 Guidelines for professionals completed Month 6<br />
M2 Initial registration completed Month 13<br />
M3 Intervention completed Month 21<br />
M4 Working conference completed Month 35<br />
Total project period: 3 years (2007-2009)<br />
Month<br />
6 12 18 24 30 36<br />
M1 M2 M3 M4
Financing<br />
EU-contribution:<br />
Own financing 1 :<br />
Total project cost:<br />
1,5 million €<br />
0,8 million €<br />
2,3 million €<br />
1 By contribution of permanent staff of the<br />
participants